1.Hoffman, GM, Tweddell, JS, Ghanayem, NS, et al. Alteration of the critical arteriovenous oxygen saturation relationship by sustained afterload reduction after the norwood procedure. J Thorac Cardiovasc Surg 2004; 127: 738–745.
2.De Oliveira, NC, Ashburn, DA, Khalid, F, et al. Prevention of early sudden circulatory collapse after the norwood operation. Circulation 2004; 110: II133–II138.
3.Thibonnier, M. Signal transduction of v1-vascular vasopressin receptors. Regul Pept 1992; 38: 1–11.
4.Mastropietro, CW, Clark, JA, Delius, RE, et al. Arginine vasopressin to manage hypoxemic infants after stage i palliation of single ventricle lesions. Pediatr Crit Care Med 2008; 9: 506–510.
5.Zingg, HH. Vasopressin and oxytocin receptors. Baillieres Clin Endocrinol Metab 1996; 10: 75–96.
6.Schafer, JA, Hawk, CT. Regulation of Na+ channels in the cortical collecting duct by avp and mineralocorticoids. Kidney Int 1992; 41: 255–268.
7.Gutkowska, J, Jankowski, M, Lambert, C, et al. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci U S A 1997; 94: 11704–11709.
8.Boarder, MR, Weisman, GA, Turner, JT, et al. G protein-coupled p2 purinoceptors: From molecular biology to functional responses. Trends Pharmacol Sci 1995; 16: 133–139.
9.Zenteno-Savin, T, Sada-Ovalle, I, Ceballos, G, et al. Effects of arginine vasopressin in the heart are mediated by specific intravascular endothelial receptors. Eur J Pharmacol 2000; 410: 15–23.
10.Maybauer, MO, Maybauer, DM, Enkhbaatar, P, et al. Physiology of the vasopressin receptors. Best Pract Res Clin Anaesthesiol 2008; 22: 253–263.
11.Mei, Q, Liang, BT. P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts. Am J Physiol Heart Circ Physiol 2001; 281: H334–H341.
12.Wernovsky, G, Wypij, D, Jonas, RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995; 92: 2226–2235.
13.Rostron, AJ, Avlonitis, VS, Cork, DM, et al. Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Transplantation 2008; 85: 597–606.
14.Mastropietro, CW, Rossi, NF, Clark, JA, et al. Relative deficiency of arginine vasopressin in children after cardiopulmonary bypass. Crit Care Med 2010; 38: 2052–2058.
15.Choong, K, Bohn, D, Fraser, DD, et al. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med 2009; 180: 632–639.
16.Rosenzweig, EB, Starc, TJ, Chen, JM, et al. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999; 100: II182–II186.
17.Lechner, E, Hofer, A, Mair, R, et al. Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass. Eur J Pediatr 2007; 166: 1221–1227.
18.Matok, I, Rubinshtein, M, Levy, A, et al. Terlipressin for children with extremely low cardiac output after open heart surgery. Ann Pharmacother 2009; 43: 423–429.